Ad
related to: confidence interval
Search results
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 6 days agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 2 days agoJohnson & Johnson today announced data from the Phase 3 PERSEUS study showing deepening of responses...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 4 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Immediate and sustained root caries prevention of fluoride varnish combined with toothpastes:...
Nature· 6 days agoEffective root caries prevention strategies are becoming increasingly important as an estimated one-third of the global elderly population is now affected by root caries with the possibility ...
Early safety data on RSV vaccines show rare Guillain-Barre cases
Center for Infectious Disease Research and Policy· 2 days agoGBS can follow bacterial or viral infections, and, rarely, follow vaccination.
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days ago- Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data further support barzolvolimab clinical benefit
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Forrest City Times-Herald· 2 days agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line treatment in patients with advanced ...
Nanoform's biologics technology showcased by large pharma at drug delivery conference;...
WROC Rochester· 7 days agoManufacturing of GMP material in Project Nanoenzalutamide commenced. Fimea's two-day inspection of...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
WLNS Lansing· 5 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC-01 clinical trial ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased to announce that Truqap™ (capivasertib) in combination with fulvestrant is
